A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication

A Phase 4, Observational, Non-interventional Study Measuring and Tracking Changes in Overactive Bladder Medication and/or Overactive Bladder Medication Dose in Subjects With Overactive Bladder

The purpose of this study is to track changes in overactive bladder (OAB) medical regimen and/or OAB medication dosage requirements.

Subjects will complete a study specific survey questionnaire at Screening and the Month 1 through Month 6 visits. Subjects will be followed for 6 months.

Inclusion Criteria:

• Subject has overactive bladder as determined by their prescribing physician
• Subject is currently receiving pharmacotherapy for overactive bladder
• Subject is willing to comply with required protocol/study requirements

Exclusion Criteria:

• Subject has a history of a clinically significant illness or medical condition prior to screening that would preclude participation in the study
• Male subjects with Lower Urinary Tract Symptoms (LUTS) or Bladder Outlet Obstruction (BOO)